Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Kaiser Permanente

Kaiser Permanente

Kaiser Permanente is a healthcare, biotechnology, and medical-based company that conducts clinical trials for vaccines

Kaiser Permanente Washington Health Research Institute (KPWHRI) is a healthcare, biotechnology, and medical-based company that looks to shape the future of healthcare. The company was founded by Henry Kaiser and Sidney Garfield in 1945, in Oakland, California, United States.

Kaiser Permanente was founded for the primary purpose of helping people live healthy lives. The company utilizes an electronic health record system in order to maintain patient scheduling, health information, as well as medications. The company assists with things such as birth control, the flu, life care planning, mental health, wellness, and various other areas of health.

KPWHRI has a vaccine research team with expertise in conducting trials for H1N1 and influenza A. In 2007, KPWHRI became a as Vaccine and Treatment Evaluation Units (VTEU) site, one of 9 VTEU centers in the USA.


Since the outbreak of COVID-19 (coronavirus), Kaiser Permanente has been monitoring the respiratory illnesses caused by the virus. The company believes they are able to help see and treat patients who have been infected with the virus, and do so with limited risk to others. Their staff has been prepared and trained for emergency scenarios including detection and treatment of infectious diseases.

On March 16, 2020, Kaiser's team began testing an investigational vaccine for SARS-CoV-2 which became the first vaccine for the 2019 novel coronavirus to be injected into a volunteer in a clinical trial. The trial was selected by the National Institute of Allergy and Infectious Diseases for conducting the clinical trial led by researcher is Lisa Jackson, MD MPH, senior investigator at Kaiser. The vaccine called mRNA-1273 was developed by Moderna and NAID researchers including Barney Graham and colleagues at the Vaccine Research Center at NIH. The vaccine includes a short segment of lab made messenger RNA. The mRNA has the genetic code for the spike protein, the part of the virus that is important for gaining entry into cells. The cells of a person injected with the mRNA will make the virus protein. It is hoped that the viral protein will stimulate the immune system to attack SARS-CoV-2. The Phase I trial with 45 participants will test safety of various doses and whether it invokes an immune response. Funding for vaccine production was provided by Coalition for Epidemic Preparedness Innovations (CEPI).


April 7, 2021
Kaiser Permanente announces that Diane Comer has been named the organization's new chief information technology officer.

Invested in


Funding Rounds Participated In

Further Resources


COVID-19: The latest information


March 13, 2020

Custom Care & Coverage Just For You | Kaiser Permanente


Health & Wellness | Kaiser Permanente



Dave Muoio
October 11, 2021
Nearly 21,000 of the nonprofit's nurses and workers based in Southern California could walk off the job, according to their union. The dispute centers around contractual pay increases they say are insufficient and will hamper recruitment during the next few years.
Dave Muoio
September 20, 2021
The union of 24,000 nurses and other healthcare professionals say that the California provider's weak pay increase proposal will lead to staffing shortages. A Kaiser representative responded by highlighting the high cost of care and union members' existing above-average compensation.
August 27, 2021
To better serve patients on the Leeward Coast of Oahu, especially seniors, Kaiser Permanente has announced a free shuttle that will run from Nanakuli to its new state-of-the-art West Oahu Medical Office in Kapolei. The shuttle will run Monday, Wednesday, and Friday mornings starting September 8. "There's been an overwhelmingly positive response from our Leeward Coast area members to the new West Oahu Medical Office," said Greg Christian, Hawaii Market president, Kaiser Foundation Health...
Heather Landi
August 11, 2021
The COVID-19 pandemic put a spotlight on existing healthcare disparities, but in communities throughout the U.S., public health leaders have been trying to tackle systemic inequities for years with limited success. Efforts have been siloed and technology has not been part of the conversation, industry leaders say.
Robert King
August 9, 2021
Kaiser Permanente posted $3 billion in profits for the second quarter of 2021 thanks in part to steady growth in its health plan.
Golden logo
By using this site, you agree to our Terms & Conditions.